Your browser doesn't support javascript.
loading
Toxicological analysis of azide and cyanide for azide intoxications using gas chromatography.
Bruin, Maaike A C; Dekker, Douwe; Venekamp, Nikkie; Tibben, Matthijs; Rosing, Hilde; de Lange, Dylan W; Beijnen, Jos H; Huitema, Alwin D R.
Affiliation
  • Bruin MAC; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Dekker D; Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Venekamp N; Department of Internal Medicine, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Tibben M; Dutch Poisons Information Center, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Rosing H; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • de Lange DW; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Beijnen JH; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Huitema ADR; Dutch Poisons Information Center, University Medical Center Utrecht, Utrecht, The Netherlands.
Basic Clin Pharmacol Toxicol ; 128(3): 534-541, 2021 Mar.
Article in En | MEDLINE | ID: mdl-33090684
ABSTRACT
Azide is a highly toxic chemical agent to human being. Accidental, but also intentional exposure to azide occurs. To be able to confirm azide ingestion, we developed a method to identify and quantify azide in biological matrices. Cyanide was included in the method to evaluate suggested in vivo production of cyanide after azide ingestion. Azide in biological matrices was first derivatized by propionic anhydride to form propionyl azide. Simultaneously, cyanide was converted into hydrogen cyanide. After thermal rearrangement of propionyl azide, ethyl isocyanate was formed, separated together with hydrogen cyanide by gas chromatography (GC) and detected using a nitrogen phosphorous detector (NPD). The method was linear from 1.0-100 µg/mL for both analytes, and azide was stable in human plasma at -20°C for at least 49 days. Azide was measured in the gastric content of two cases of suspected azide ingestion (case 11.2 mg/mL, case 21.5 mg/mL). Cyanide was only identified in the gastric content of case 1 (approximately 1.4 µg/mL). Furthermore, azide was quantified in plasma (19 µg/mL), serum (24 µg/mL), cell pellet (21 µg/mL) and urine (3.0 µg/mL) of case 2. This method can be used to confirm azide and cyanide exposure, and azide concentrations can be quantified in several biological matrices.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Azides / Chromatography, Gas / Cyanides Type of study: Prognostic_studies Limits: Adult / Female / Humans Language: En Journal: Basic Clin Pharmacol Toxicol Journal subject: FARMACOLOGIA / TOXICOLOGIA Year: 2021 Type: Article Affiliation country: Netherlands

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Azides / Chromatography, Gas / Cyanides Type of study: Prognostic_studies Limits: Adult / Female / Humans Language: En Journal: Basic Clin Pharmacol Toxicol Journal subject: FARMACOLOGIA / TOXICOLOGIA Year: 2021 Type: Article Affiliation country: Netherlands